Compass Therapeutics (CMPX) Return on Invested Capital (2020 - 2022)

Compass Therapeutics has disclosed Return on Invested Capital across 3 years of filings, most recently posting 0.0% for Q3 2022.

• Return on Invested Capital for Q3 2022 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was 0.0% (changed N/A YoY), and the FY2020 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q3 2022 at Compass Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q2 2020 to a low of 0.01% in Q1 2021.
• The 3-year median for Return on Invested Capital is 0.0% (2022), against an average of 0.0%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Compass Therapeutics' Return on Invested Capital stood at 0.0% in 2020, then slipped by 21 bps to 0.0% in 2021, then advanced by 18 bps to 0.0% in 2022.
• The last three Return on Invested Capital figures came in at 0.0% (Q3 2022), 0.0% (Q2 2022), and 0.0% (Q1 2022), per Business Quant data.